Poor Antibody Response after Two Doses of SARS-CoV-2 vaccine in Transplant Recipients
Abstract
A low anti-spike antibody response of 28.6% was observed 28 days after BNT162b2 vaccine second dose among 133 solid organ transplant-recipients without previous COVID-19. No serious adverse events were recorded. Four severe COVID-19 cases were reported between or after the two doses. Our data suggests to change the vaccine strategy.
Fichier principal
Mazzola et al. - 2021 - Poor Antibody Response after Two Doses of SARS-CoV.pdf (217.28 Ko)
Télécharger le fichier
| Origin | Files produced by the author(s) |
|---|